Wyss InstituteCancer – Wyss Institute https://wyss.stage.a17.io Wyss Institute at Harvard Thu, 30 Jul 2026 21:38:59 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.6 20-ish Questions with Natalie Artzi https://wyss.stage.a17.io/media-post/20-ish-questions-with-natalie-artzi/ Mon, 18 Nov 2024 19:37:29 +0000 https://wyss.harvard.edu/?post_type=media_post&p=41494 20-ish Questions shows a different side of Wyss Institute faculty, touching on aspects of their personal life, hobbies, interests, as well as their research. This round follows Natalie Artzi, a new addition to the Wyss Institute’s Core Faculty. Credit: Wyss Institute at Harvard University…

Source

]]> https://wyss.stage.a17.io/media-post/20-ish-questions-with-natalie-artzi/ https://wyss-stage.imgix.net/app/uploads/2024/11/18143719/THUMBNAIL_20ish-Questions-with-Natalie-Artzi_No-Text.jpg?auto=format%2Ccompress&crop=faces%2Centropy&fit=crop&h=400&q=50&w=300&s=4e923726dcf32c8b67c709d6383c74a2"/> Wyss Institute’s iNodes team receives ARPA-H Sprint for Women’s Health award to advance the first implantable immune organs to treat ovarian cancer https://wyss.stage.a17.io/news/inodes-receives-arpa-h-award/ Tue, 12 Nov 2024 14:58:41 +0000 https://wyss.harvard.edu/?p=41442 iNodes is a new treatment paradigm in personalized immunotherapy with the potential to prolong the lives of many patients with advanced ovarian cancer By Benjamin Boettner (BOSTON) — Ovarian cancer is more deadly than any other type of female reproductive organ cancer. It is estimated that in 2024, in the U.S. alone, more than 12,000 women will die from the disease because available therapies are not effective. To help overcome this striking deficit in women’s health, ARPA-H has selected a team at the Wyss Institute at Harvard University as…

Source

]]> https://wyss.stage.a17.io/news/inodes-receives-arpa-h-award/ Gigija Goyal, Senior Scientist II. Credit: Wyss Institute at Harvard University https://wyss-stage.imgix.net/app/uploads/2022/02/03113258/WoW-Girija-Goyal-Neutral-2081.jpg?auto=format%2Ccompress&crop=faces%2Centropy&fit=crop&h=400&q=50&w=300&s=503aad01b8edf087abbae2069ea5b85b"/> Kwasi Adu-Berchie named 2024 STAT Wunderkind https://wyss.stage.a17.io/news/kwasi-adu-berchie-named-2024-stat-wunderkind/ Wed, 16 Oct 2024 14:11:12 +0000 https://wyss.harvard.edu/?p=41197 The honor is bestowed annually on the next generation of scientific superstars By Lindsay Brownell (BOSTON) – The Wyss Institute is thrilled to announce that Kwasi Adu-Berchie, Ph.D., a member of the Wyss’ Advanced Technology Team working in Immuno-Materials Platform led by Core Faculty member Dave Mooney, Ph.D., has been named a 2024 STAT Wunderkind by STAT News. The Wunderkinds awards are given annually by STAT News to the next generation of scientific superstars who…

Source

]]> https://wyss.stage.a17.io/news/kwasi-adu-berchie-named-2024-stat-wunderkind/ Kwasi Adu-Berchie https://wyss-stage.imgix.net/app/uploads/2022/08/10092956/Kwasi-Adu-Berchie-3.jpg?auto=format%2Ccompress&crop=faces%2Centropy&fit=crop&h=400&q=50&w=300&s=4a6a7501c813f36b02821b455fa1d73c"/> Progress, Potential, and Possibilities with Luba Perry, Ph.D. – Bioengineered Breast Reconstruction And Augmentation https://wyss.stage.a17.io/media-post/progress-potential-and-possibilities-with-luba-perry-ph-d-bioengineered-breast-reconstruction-and-augmentation/ Tue, 08 Oct 2024 14:24:03 +0000 https://wyss.harvard.edu/?post_type=media_post&p=41160 Each episode of this podcast includes a discussion with fascinating people designing a better tomorrow. Luba Perry, Ph.D. is Co-Founder and CEO of ReConstruct Bio, an innovative venture emerging from Harvard’s Wyss Institute, aimed at redefining the fields of medical reconstruction and aesthetics with an initial application of their groundbreaking technology on breast reconstruction and…

Source

]]> https://wyss.stage.a17.io/media-post/progress-potential-and-possibilities-with-luba-perry-ph-d-bioengineered-breast-reconstruction-and-augmentation/ Luba Perry, Postdoctoral Fellow. Credit: Wyss Institute at Harvard University https://wyss-stage.imgix.net/app/uploads/2021/06/21103731/HoW-Luba-Perry-0740.jpg?auto=format%2Ccompress&crop=faces%2Centropy&fit=crop&h=400&q=50&w=300&s=df27314b47a1b42b2a4d8ab4b0e8cd37"/> DoriNano – Improved DNA Origami Nanodelivery to Fight Cancer and Other Diseases https://wyss.stage.a17.io/media-post/dorinano-improved-dna-origami-nanodelivery-to-fight-cancer-and-other-diseases/ Fri, 04 Oct 2024 18:20:45 +0000 https://wyss.harvard.edu/?post_type=media_post&p=41135 We’re developing DNA Origami nanodelivery, which is transforming nanoparticle industry. Developed at the Dana Farber Cancer Institute and the Wyss Institute at Harvard University, this innovative approach overcomes the challenges of other nanoparticles, offering stability, high drug loading capacity, nano-scale control of cargo spacing, and more – making it a highly customizable solution for…

Source

]]> https://wyss.stage.a17.io/media-post/dorinano-improved-dna-origami-nanodelivery-to-fight-cancer-and-other-diseases/ https://wyss-stage.imgix.net/app/uploads/2024/10/04142026/THUMBNAIL-DoriNano-Improved-DNA-Origami-Nanodelivery-to-Fight-Cancer-and-Other-Diseases_No-Text.jpg?auto=format%2Ccompress&crop=faces%2Centropy&fit=crop&h=400&q=50&w=300&s=08966c8c9814bdc45a545eadd20ac7bd"/> Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies https://wyss.stage.a17.io/news/attivare-licenses-wyss-institutes-immune-modulating-biomaterial-technology-to-advance-immunotherapies/ Wed, 02 Oct 2024 13:20:13 +0000 https://wyss.harvard.edu/?p=41088 The startup is leveraging the biomaterial-based technology to develop novel therapies able to program anti-cancer immunity and prevent infectious diseases By Benjamin Boettner (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Attivare Therapeutics Inc. announced that Attivare has licensed a portfolio of immune-modulating biomaterial technologies from Harvard University that was created at the Wyss Institute, John A. Paulson School of Engineering and Applied Sciences (SEAS)…

Source

]]> https://wyss.stage.a17.io/news/attivare-licenses-wyss-institutes-immune-modulating-biomaterial-technology-to-advance-immunotherapies/ The OMNIVAX infection vaccine approach incorporates pathogen-derived antigens into an injectable biomaterial scaffold which presents them together with immune cell attracting and activating factors to dendritic immune cells that then go on to orchestrate multi-faceted immune responses against the pathogen in nearby lymph nodes. Credit: Wyss Institute at Harvard University https://wyss-stage.imgix.net/app/uploads/2020/05/20143742/MPS-Scaffold-SEM-001-e1590000157764.jpeg?auto=format%2Ccompress&crop=faces%2Centropy&fit=crop&h=400&q=50&w=300&s=b22cd283948c2a998b8ada8474c9e03f"/> Eliz Amar Lewis on Using Many Tools to Fight a Sophisticated Disease https://wyss.stage.a17.io/news/humans-of-the-wyss-eliz-amar-lewis-on-using-many-tools-to-fight-a-sophisticated-disease/ Tue, 24 Sep 2024 14:50:19 +0000 https://wyss.harvard.edu/?p=41047 The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Eliz Amar Lewis has always been fascinated by biology. But when she saw her grandmother bravely battle breast cancer, she was inspired to use her passion to develop a smart and sophisticated…

Source

]]> https://wyss.stage.a17.io/news/humans-of-the-wyss-eliz-amar-lewis-on-using-many-tools-to-fight-a-sophisticated-disease/ Eliz Amar Lewis, Postdoctoral Fellow. Credit: Wyss Institute at Harvard University https://wyss-stage.imgix.net/app/uploads/2024/09/23140755/dsRNA-Eliz-Amar-Lewis-07336.jpg?auto=format%2Ccompress&crop=faces%2Centropy&fit=crop&h=400&q=50&w=300&s=8f758cb4d1a3a71b4ba9df3c9617f9a3"/> Starting a fluorescent biosensor revolution https://wyss.stage.a17.io/news/starting-a-fluorescent-biosensor-revolution/ Thu, 05 Sep 2024 09:00:00 +0000 https://wyss.harvard.edu/?p=40904 Molecular biosensors that only light up upon binding their targets open vast possibilities for medical diagnostics, fundamental research, environmental monitoring, and more By Benjamin Boettner (BOSTON) — Biosensors – devices that use biological molecules to detect the presence of a target substance – have enormous potential for detecting disease biomarkers, molecules-in-action in diverse biological processes, or toxins and other harmful substances in the environment. One of the more common types, fluorescent biosensors, consists of a target-binding biomolecule…

Source

]]> https://wyss.stage.a17.io/news/starting-a-fluorescent-biosensor-revolution/ As an “instant COVID-19 diagnostic,” a binding-activated biosensor, developed to bind the Spike protein of the SARS-CoV-2 virus, is able to detect its target within milliseconds as shown by the development of green fluorescence in this sample. Credit: Wyss Institute at Harvard University https://wyss-stage.imgix.net/app/uploads/2024/09/03234828/Fluorescent-Biosensor_Squeeze.jpg?auto=format%2Ccompress&crop=faces%2Centropy&fit=crop&h=400&q=50&w=300&s=6e0ac9a6202adb965f6d55a4958f4317"/> Vinny Chandran Suja on Making Backpacks More Reliable and Predictable https://wyss.stage.a17.io/news/humans-of-the-wyss-vinny-chandran-suja-on-making-backpacks-more-reliable-and-predictable/ Tue, 20 Aug 2024 13:10:41 +0000 https://wyss.harvard.edu/?p=40839 The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. As a kid, Vinny Chandran Suja had no interest in biology. Instead, his math and science acumen led him to pursue degrees in mechanical and chemical engineering, studying non-living systems.

Source

]]> https://wyss.stage.a17.io/news/humans-of-the-wyss-vinny-chandran-suja-on-making-backpacks-more-reliable-and-predictable/ Vinny Chandran Suja, Postdoctoral Fellow. Credit: Wyss Institute at Harvard University https://wyss-stage.imgix.net/app/uploads/2024/08/19095508/HoW-Vinny-Suja-04607.jpg?auto=format%2Ccompress&crop=faces%2Centropy&fit=crop&h=400&q=50&w=300&s=bdf61545789ef6d11eb055eb87b90950"/> Wyss Institute promotes Natalie Artzi to its Core Faculty and appoints Di Feng as an Associate Faculty member https://wyss.stage.a17.io/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/ Mon, 12 Aug 2024 13:15:25 +0000 https://wyss.harvard.edu/?p=40759 Artzi’s promotion and Feng’s appointment strengthen the Institute’s efforts in nanomedicine and immunoengineering, as well as modeling of chronic kidney diseases By Benjamin Boettner (BOSTON) — Natalie Artzi, Ph.D., joined the ranks of the Wyss Institute’s now 12 Core Faculty members after only two years as an Associate Faculty member. Artzi’s promotion reflects her exceptional commitment to the Institute’s mission and the deep engagements and collaborations she has initiated within its technology development community. The Wyss Institute also warmly…

Source

]]> https://wyss.stage.a17.io/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/ In August, we announced <a href="https://wyss.harvard.edu/news/wyss-institute-promotes-natalie-artzi-to-its-core-faculty-and-appoints-di-feng-as-an-associate-faculty-member/">Natalie Artzi’s promotion to Core Faculty member and the appointment of Di Feng</a> as an Associate Faculty member. Credit: Wyss Institute at Harvard University https://wyss-stage.imgix.net/app/uploads/2024/08/08145256/ArtziFengComposite.jpg?auto=format%2Ccompress&crop=faces%2Centropy&fit=crop&h=400&q=50&w=300&s=1c298d6dde25ec80aa1f9fe30f99b0fd"/>